By Elaine Donnelly
Extending sexual misconduct to combat units
Independent voices from the TWT Communities
The European Union's top court ruled Tuesday that scientists cannot patent stem cell techniques that use human embryos for research, a decision some scientists said could threaten major medical advances if it prevents biotech companies from turning a profit.
Several Massachusetts firms are forging ahead with ambitious stem-cell research plans, circumventing the heated debate over embryonic research by using other, less-controversial methods.
But, he said, other techniques, such as those used by his company, would not be banned.
"We're also hoping to see some improvement in visual acuity, but that's a bonus," said Dr. Robert Lanza, ACT's chief scientific officer.